Why are potential pain therapies getting lost in translation?
It is estimated that 1.5 billion people worldwide suffer from Chronic pain. While research has seen...
Monitoring pain in EAE animals experiencing paralysis
Many neurodegenerative diseases such as Multiple Sclerosis, ALS, and Rhett Syndrome involve...
3 ways to improve clinical relevance of preclinical CNS data
The success rate from first candidate to market launch is less than 1%, requiring approximately 22...
Pain Studies In Pig: advantages for nerve blocks, local & systemic therapies
MD Biosciences lab has an exclusive expertise in pain studies in the pig. Our scientists have...
Weekly Science Blog: Possible Therapies for Spinal Cord Injuries, Reversal for Inflammatory Diseases and More!
It's Tuesday, which means MD Biosciences is providing coverage of the latest fascinating and...
MDB Neuropathic Pain Porcine Model Publication Featured in Neurobiology of Pain Journal
MDB Scientists recently published a paper titled “Human-like cutaneous neuropathologies associated...
Behavioral Research Assessments & Applications: Quantify Cognitive, Emotional, Sensory & Motor Functions
Neurological diseases often result in a combination of motor and cognitive deficits. Thus,...
Glatiramer Acetate (Copaxone® Generics) and Batch Release Testing in MS/EAE at MD Biosciences
MDB Gains OECD-GLP certification for In Vivo Glatiramer Acetate Batch Release Testing Services
Why the Pig is a Good Preclinical Model for Wound Healing
There are many options for preclinical wound healing research. All studies are designed to predict...